A citation-based method for searching scientific literature

MicroRNAs, Multiple Sclerosis, and Depression.
Hsiuying Wang. Int J Mol Sci 2021
Times Cited: 6






Login to export Results
Don't have an account? Register here

List of co-cited articles
35 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Comparison of antidepressant and side effects in mice after intranasal administration of (R,S)-ketamine, (R)-ketamine, and (S)-ketamine.
Lijia Chang, Kai Zhang, Yaoyu Pu, Youge Qu, Si-Ming Wang, Zhongwei Xiong, Qian Ren, Chao Dong, Yuko Fujita, Kenji Hashimoto. Pharmacol Biochem Behav 2019
77
2
33

The second brain: The connection between gut microbiota composition and multiple sclerosis.
Melina Farshbafnadi, Elmira Agah, Nima Rezaei. J Neuroimmunol 2021
7
2
33

A historical review of antidepressant effects of ketamine and its enantiomers.
Yan Wei, Lijia Chang, Kenji Hashimoto. Pharmacol Biochem Behav 2020
73
2
33

(R)-Ketamine ameliorates lethal inflammatory responses and multi-organ injury in mice induced by cecum ligation and puncture.
Jiancheng Zhang, Li Ma, Yaeko Hashimoto, Xiayun Wan, Jiajing Shan, Youge Qu, Kenji Hashimoto. Life Sci 2021
11
2
33

Depression in multiple sclerosis: Is one approach for its management enough?
C Danielle Jones, Robert Motl, Brian M Sandroff. Mult Scler Relat Disord 2021
8
2
33

An update on ketamine and its two enantiomers as rapid-acting antidepressants.
Kai Zhang, Kenji Hashimoto. Expert Rev Neurother 2019
64
2
33

Annual Cost Burden by Level of Relapse Severity in Patients with Multiple Sclerosis.
Jacqueline Nicholas, Huanxue Zhou, Chinmay Deshpande. Adv Ther 2021
5
2
40

Comparison of (R)-ketamine and lanicemine on depression-like phenotype and abnormal composition of gut microbiota in a social defeat stress model.
Youge Qu, Chun Yang, Qian Ren, Min Ma, Chao Dong, Kenji Hashimoto. Sci Rep 2017
72
2
33

Rapid-acting and long-lasting antidepressant-like action of (R)-ketamine in Nrf2 knock-out mice: a role of TrkB signaling.
Youge Qu, Jiajing Shan, Siming Wang, Lijia Chang, Yaoyu Pu, Xingming Wang, Yunfei Tan, Masayuki Yamamoto, Kenji Hashimoto. Eur Arch Psychiatry Clin Neurosci 2021
18
2
33

Role of Inflammatory Bone Markers in the Antidepressant Actions of (R)-Ketamine in a Chronic Social Defeat Stress Model.
Kai Zhang, Min Ma, Chao Dong, Kenji Hashimoto. Int J Neuropsychopharmacol 2018
14
2
33

Antidepressant Potential of (R)-Ketamine in Rodent Models: Comparison with (S)-Ketamine.
Kenichi Fukumoto, Hidetoh Toki, Michihiko Iijima, Takashi Hashihayata, Jun-Ichi Yamaguchi, Kenji Hashimoto, Shigeyuki Chaki. J Pharmacol Exp Ther 2017
142
2
33

Rapid-acting antidepressant ketamine, its metabolites and other candidates: A historical overview and future perspective.
Kenji Hashimoto. Psychiatry Clin Neurosci 2019
153
2
33

Pharmacological and behavioral divergence of ketamine enantiomers: implications for abuse liability.
Jordi Bonaventura, Sherry Lam, Meghan Carlton, Matthew A Boehm, Juan L Gomez, Oscar Solís, Marta Sánchez-Soto, Patrick J Morris, Ida Fredriksson, Craig J Thomas,[...]. Mol Psychiatry 2021
58
2
33

Molecular mechanisms underlying the antidepressant actions of arketamine: beyond the NMDA receptor.
Yan Wei, Lijia Chang, Kenji Hashimoto. Mol Psychiatry 2022
59
2
33

(R)-Ketamine attenuates LPS-induced endotoxin-derived delirium through inhibition of neuroinflammation.
Jiancheng Zhang, Li Ma, Xiayun Wan, Jiajing Shan, Youge Qu, Kenji Hashimoto. Psychopharmacology (Berl) 2021
19
2
33

Ketamine: A tale of two enantiomers.
Luke A Jelen, Allan H Young, James M Stone. J Psychopharmacol 2021
49
2
33

Splenic NKG2D confers resilience versus susceptibility in mice after chronic social defeat stress: beneficial effects of (R)-ketamine.
Kai Zhang, Akemi Sakamoto, Lijia Chang, Youge Qu, Siming Wang, Yaoyu Pu, Yunfei Tan, Xingming Wang, Yuko Fujita, Tamaki Ishima,[...]. Eur Arch Psychiatry Clin Neurosci 2021
25
2
33

Risk of psychosis after repeated intermittent administration of (S)-ketamine, but not (R)-ketamine, in mice.
Yunfei Tan, Kenji Hashimoto. J Affect Disord 2020
11
2
33

Depression in multiple sclerosis: a review.
R J Siegert, D A Abernethy. J Neurol Neurosurg Psychiatry 2005
423
2
33

Possible role of the gut microbiota-brain axis in the antidepressant effects of (R)-ketamine in a social defeat stress model.
Chun Yang, Youge Qu, Yuko Fujita, Qian Ren, Min Ma, Chao Dong, Kenji Hashimoto. Transl Psychiatry 2017
122
2
33

Decreased bone mineral density in ovariectomized mice is ameliorated after subsequent repeated intermittent administration of (R)-ketamine, but not (S)-ketamine.
Yuko Fujita, Kenji Hashimoto. Neuropsychopharmacol Rep 2020
9
2
33

Intravenous arketamine for treatment-resistant depression: open-label pilot study.
Gustavo C Leal, Igor D Bandeira, Fernanda S Correia-Melo, Manuela Telles, Rodrigo P Mello, Flavia Vieira, Cassio S Lima, Ana Paula Jesus-Nunes, Lívia N F Guerreiro-Costa, Roberta F Marback,[...]. Eur Arch Psychiatry Clin Neurosci 2021
103
2
33

Molecular and cellular mechanisms underlying the antidepressant effects of ketamine enantiomers and its metabolites.
Chun Yang, Jianjun Yang, Ailin Luo, Kenji Hashimoto. Transl Psychiatry 2019
88
2
33

Beneficial effects of (R)-ketamine, but not its metabolite (2R,6R)-hydroxynorketamine, in the depression-like phenotype, inflammatory bone markers, and bone mineral density in a chronic social defeat stress model.
Zhongwei Xiong, Yuko Fujita, Kai Zhang, Yaoyu Pu, Lijia Chang, Min Ma, Jincao Chen, Kenji Hashimoto. Behav Brain Res 2019
25
2
33

Economic Burden of Multiple Sclerosis in Low- and Middle-Income Countries: A Systematic Review.
Jalal Dahham, Rana Rizk, Ingrid Kremer, Silvia M A A Evers, Mickaël Hiligsmann. Pharmacoeconomics 2021
13
2
33

Mechanistic Target of Rapamycin-Independent Antidepressant Effects of (R)-Ketamine in a Social Defeat Stress Model.
Chun Yang, Qian Ren, Youge Qu, Ji-Chun Zhang, Min Ma, Chao Dong, Kenji Hashimoto. Biol Psychiatry 2018
138
2
33

R-ketamine: a rapid-onset and sustained antidepressant without psychotomimetic side effects.
C Yang, Y Shirayama, J-c Zhang, Q Ren, W Yao, M Ma, C Dong, K Hashimoto. Transl Psychiatry 2015
336
2
33

NMDAR inhibition-independent antidepressant actions of ketamine metabolites.
Panos Zanos, Ruin Moaddel, Patrick J Morris, Polymnia Georgiou, Jonathan Fischell, Greg I Elmer, Manickavasagom Alkondon, Peixiong Yuan, Heather J Pribut, Nagendra S Singh,[...]. Nature 2016
873
2
33

Molecular mechanisms of the rapid-acting and long-lasting antidepressant actions of (R)-ketamine.
Kenji Hashimoto. Biochem Pharmacol 2020
76
2
33

Targeting the gut to treat multiple sclerosis.
Laura Ghezzi, Claudia Cantoni, Gabriela V Pinget, Yanjiao Zhou, Laura Piccio. J Clin Invest 2021
13
2
33

Reduction of dopamine D2/3 receptor binding in the striatum after a single administration of esketamine, but not R-ketamine: a PET study in conscious monkeys.
Kenji Hashimoto, Takeharu Kakiuchi, Hiroyuki Ohba, Shingo Nishiyama, Hideo Tsukada. Eur Arch Psychiatry Clin Neurosci 2017
83
2
33

Loss of parvalbumin-immunoreactivity in mouse brain regions after repeated intermittent administration of esketamine, but not R-ketamine.
Chun Yang, Mei Han, Ji-Chun Zhang, Qian Ren, Kenji Hashimoto. Psychiatry Res 2016
66
2
33

Intravenous Esketamine in Adult Treatment-Resistant Depression: A Double-Blind, Double-Randomization, Placebo-Controlled Study.
Jaskaran B Singh, Maggie Fedgchin, Ella Daly, Liwen Xi, Caroline Melman, Geert De Bruecker, Andre Tadic, Pascal Sienaert, Frank Wiegand, Husseini Manji,[...]. Biol Psychiatry 2016
225
2
33

Animal models of multiple sclerosis: Focus on experimental autoimmune encephalomyelitis.
Ivana Bjelobaba, Vesna Begovic-Kupresanin, Sanja Pekovic, Irena Lavrnja. J Neurosci Res 2018
81
2
33

Dextran sulfate sodium-induced inflammation and colitis in mice are ameliorated by (R)-ketamine, but not (S)-ketamine: A role of TrkB signaling.
Yuko Fujita, Yaeko Hashimoto, Hiroyo Hashimoto, Lijia Chang, Kenji Hashimoto. Eur J Pharmacol 2021
8
2
33

Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS).
Cris S Constantinescu, Nasr Farooqi, Kate O'Brien, Bruno Gran. Br J Pharmacol 2011
779
1
16

Role of Gut Microbiota in Multiple Sclerosis and Potential Therapeutic Implications.
Xu Wang, Zhen Liang, Shengnan Wang, Di Ma, Mingqin Zhu, Jiachun Feng. Curr Neuropharmacol 2022
4
1
25

The roles of macrophages and microglia in multiple sclerosis and experimental autoimmune encephalomyelitis.
Fengna Chu, Mingchao Shi, Chao Zheng, Donghui Shen, Jie Zhu, Xiangyu Zheng, Li Cui. J Neuroimmunol 2018
149
1
16

Depression in multiple sclerosis.
S B Patten, L M Metz. Psychother Psychosom 1997
73
1
16

Sodium channels contribute to microglia/macrophage activation and function in EAE and MS.
Matthew J Craner, Tina G Damarjian, Shujun Liu, Bryan C Hains, Albert C Lo, Joel A Black, Jia Newcombe, M Louise Cuzner, Stephen G Waxman. Glia 2005
188
1
16

Depression in multiple sclerosis: a review of assessment and treatment approaches in adult and pediatric populations.
Maria Skokou, Evanthia Soubasi, Philippos Gourzis. ISRN Neurol 2012
43
1
16

Comparative efficacy of racemic ketamine and esketamine for depression: A systematic review and meta-analysis.
Anees Bahji, Gustavo H Vazquez, Carlos A Zarate. J Affect Disord 2021
80
1
16

Risk of Psychiatric Disorders in Multiple Sclerosis: A Nationwide Cohort Study in an Asian Population.
Yao-Ching Huang, Wu-Chien Chien, Chi-Hsiang Chung, Hsin-An Chang, Yu-Chen Kao, Fang-Jung Wan, Shi-Hao Huang, Ren-Jei Chung, Richard S Wang, Bing-Long Wang,[...]. Neuropsychiatr Dis Treat 2021
1
1
100

Structure, Function, and Regulation of the Blood-Brain Barrier Tight Junction in Central Nervous System Disorders.
Jeffrey J Lochhead, Junzhi Yang, Patrick T Ronaldson, Thomas P Davis. Front Physiol 2020
92
1
16

The experimental autoimmune encephalomyelitis (EAE) model of MS: utility for understanding disease pathophysiology and treatment.
Andrew P Robinson, Christopher T Harp, Avertano Noronha, Stephen D Miller. Handb Clin Neurol 2014
254
1
16

Expression of heat shock protein HSP-70 in the retrosplenial cortex of rat brain after administration of (R,S)-ketamine and (S)-ketamine, but not (R)-ketamine.
Zheng Tian, Chao Dong, Atsuhiro Fujita, Yuko Fujita, Kenji Hashimoto. Pharmacol Biochem Behav 2018
36
1
16

Claudin-5: gatekeeper of neurological function.
Chris Greene, Nicole Hanley, Matthew Campbell. Fluids Barriers CNS 2019
163
1
16

TRPA1 involvement in depression- and anxiety-like behaviors in a progressive multiple sclerosis model in mice.
Diulle Spat Peres, Maria Carolina Theisen, Maria Fernanda Pessano Fialho, Diéssica Padilha Dalenogare, Patrícia Rodrigues, Sabrina Qader Kudsi, Laura de Barros Bernardes, Náthaly Andrighetto Ruviaro da Silva, Débora Denardin Lückemeyer, Tuane Bazanella Sampaio,[...]. Brain Res Bull 2021
7
1
16

Animal Models of MS Reveal Multiple Roles of Microglia in Disease Pathogenesis.
Zhen Gao, Stella E Tsirka. Neurol Res Int 2011
80
1
16

Role of microglia in multiple sclerosis.
Xinqing Deng, Subramaniam Sriram. Curr Neurol Neurosci Rep 2005
15
1
16


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.

Longstocking, LLC. © 2021
Home | About Us | FAQs | Terms & Privacy